Syros Pharmaceuticals Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Syros Pharmaceuticals (SYRS) IPO Pushes Higher Into the Close
June 30, 2016 3:10 PM EDTToday's IPO for Syros Pharmaceuticals (NASDAQ: SYRS) is pressing higher into the close. Shares last traded up 46.8% to $18.35 after pricing at $12.50 and opening at $15 earlier today.
... MoreSyros Pharmaceuticals (SYRS) IPO Opens Up 20%
June 30, 2016 11:20 AM EDTToday's IPO for Syros Pharmaceuticals (Nasdaq: SYRS) opened for trading at $15 after pricing its initial public offering of 4,000,000 shares of its common stock at a public offering price of $12.50 per share. The company was previously expecting the IPO to price from $14 to $16 per... More
